CEO and Co-Founder at Duo Oncology - Pittsburgh, PA, US
Director Of Operations
Contact Katie Eichinger
Right now, 60-80% of patients show little response to standard immunotherapy or chemotherapy. Duo Oncology plans to transform patient outcomes with a new type of nanotherapy.